A citation-based method for searching scientific literature

Susan Garfield, Julie Polisena, Daryl S Spinner, Anne Postulka, Christine Y Lu, Simrandeep K Tiwana, Eric Faulkner, Nick Poulios, Vladimir Zah, Michael Longacre. Value Health 2016
Times Cited: 19







List of co-cited articles
47 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group.
Eric Faulkner, Lieven Annemans, Lou Garrison, Mark Helfand, Anke-Peggy Holtorf, John Hornberger, Dyfrig Hughes, Tracy Li, Daniel Malone, Katherine Payne,[...]. Value Health 2012
82
15

How is genetic testing evaluated? A systematic review of the literature.
Erica Pitini, Corrado De Vito, Carolina Marzuillo, Elvira D'Andrea, Annalisa Rosso, Antonio Federici, Emilio Di Maria, Paolo Villari. Eur J Hum Genet 2018
38
15

Insurance coverage policies for personalized medicine.
Andrew Hresko, Susanne B Haga. J Pers Med 2012
62
10

Molecular diagnostics clinical utility strategy: a six-part framework.
Felix W Frueh, Bruce Quinn. Expert Rev Mol Diagn 2014
10
20

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.
Steven M Teutsch, Linda A Bradley, Glenn E Palomaki, James E Haddow, Margaret Piper, Ned Calonge, W David Dotson, Michael P Douglas, Alfred O Berg. Genet Med 2009
492
10

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
Tony S Mok, Yi-Long Wu, Sumitra Thongprasert, Chih-Hsin Yang, Da-Tong Chu, Nagahiro Saijo, Patrapim Sunpaweravong, Baohui Han, Benjamin Margono, Yukito Ichinose,[...]. N Engl J Med 2009
10

Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis.
Marie Westwood, Manuela Joore, Penny Whiting, Thea van Asselt, Bram Ramaekers, Nigel Armstrong, Kate Misso, Johan Severens, Jos Kleijnen. Health Technol Assess 2014
27
10

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.
S Patton, N Normanno, F Blackhall, S Murray, K M Kerr, M Dietel, M Filipits, S Benlloch, S Popat, R Stahel,[...]. Br J Cancer 2014
35
10

KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis.
Marie Westwood, Thea van Asselt, Bram Ramaekers, Penny Whiting, Manuela Joore, Nigel Armstrong, Caro Noake, Janine Ross, Johan Severens, Jos Kleijnen. Health Technol Assess 2014
53
10

Treatment of periprosthetic infections: an economic analysis.
Daniel Hernández-Vaquero, Mariano Fernández-Fairen, Ana Torres, Ann M Menzie, José Manuel Fernández-Carreira, Antonio Murcia-Mazon, Enrique Guerado, Luis Merzthal. ScientificWorldJournal 2013
37
10

Diagnosis of periprosthetic joint infection in Medicare patients: multicriteria decision analysis.
Claudio Diaz-Ledezma, Paul M Lichstein, James G Dolan, Javad Parvizi. Clin Orthop Relat Res 2014
21
10

Descriptive analysis of the economic costs of periprosthetic joint infection of the knee for the public health system of Andalusia.
J Garrido-Gómez, M A Arrabal-Polo, M S Girón-Prieto, J Cabello-Salas, J Torres-Barroso, J Parra-Ruiz. J Arthroplasty 2013
26
10

Health technology assessment of medical devices: What is different? An overview of three European projects.
Petra Schnell-Inderst, Julia Mayer, Jörg Lauterberg, Theresa Hunger, Marjan Arvandi, Annette Conrads-Frank, Anna Nachtnebel, Claudia Wild, Uwe Siebert. Z Evid Fortbild Qual Gesundhwes 2015
20
10


Economic evaluations of personalized medicine: existing challenges and current developments.
Fatiha H Shabaruddin, Nigel D Fleeman, Katherine Payne. Pharmgenomics Pers Med 2015
25
10

Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers.
Mark R Trusheim, Ernst R Berndt, Frank L Douglas. Nat Rev Drug Discov 2007
296
10

Cost-effectiveness analyses of genetic and genomic diagnostic tests.
Katherine Payne, Sean P Gavan, Stuart J Wright, Alexander J Thompson. Nat Rev Genet 2018
56
10

Current methodological issues in the economic assessment of personalized medicine.
Lieven Annemans, Ken Redekop, Katherine Payne. Value Health 2013
50
10

Toward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions.
Katherine Payne, Martin Eden, Niall Davison, Egbert Bakker. Per Med 2017
14
14


The Health Technology Assessment of companion diagnostics: experience of NICE.
Sarah K Byron, Nick Crabb, Elisabeth George, Mirella Marlow, Adrian Newland. Clin Cancer Res 2014
17
11

Concepts of 'personalization' in personalized medicine: implications for economic evaluation.
Wolf Rogowski, Katherine Payne, Petra Schnell-Inderst, Andrea Manca, Ursula Rochau, Beate Jahn, Oguzhan Alagoz, Reiner Leidl, Uwe Siebert. Pharmacoeconomics 2015
45
10

Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.
Kevin Marsh, Maarten IJzerman, Praveen Thokala, Rob Baltussen, Meindert Boysen, Zoltán Kaló, Thomas Lönngren, Filip Mussen, Stuart Peacock, John Watkins,[...]. Value Health 2016
197
10

Health technology assessment, value-based decision making, and innovation.
Chris Henshall, Tara Schuller. Int J Technol Assess Health Care 2013
48
10

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.
Fred R Hirsch, Abigail McElhinny, Dave Stanforth, James Ranger-Moore, Malinka Jansson, Karina Kulangara, William Richardson, Penny Towne, Debra Hanks, Bharathi Vennapusa,[...]. J Thorac Oncol 2017
815
10

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
10

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project.
Ming Sound Tsao, Keith M Kerr, Mark Kockx, Mary-Beth Beasley, Alain C Borczuk, Johan Botling, Lukas Bubendorf, Lucian Chirieac, Gang Chen, Teh-Ying Chou,[...]. J Thorac Oncol 2018
399
10

A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer.
David L Rimm, Gang Han, Janis M Taube, Eunhee S Yi, Julia A Bridge, Douglas B Flieder, Robert Homer, William W West, Hong Wu, Anja C Roden,[...]. JAMA Oncol 2017
496
10

A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA.
Stuart Hogarth, Michael M Hopkins, Victor Rodriguez. Sociol Health Illn 2012
17
11



Common evidence gaps in point-of-care diagnostic test evaluation: a review of horizon scan reports.
Jan Y Verbakel, Philip J Turner, Matthew J Thompson, Annette Plüddemann, Christopher P Price, Bethany Shinkins, Ann Van den Bruel. BMJ Open 2017
31
10

Advancing prevention of sexually transmitted infections through point-of-care testing: target product profiles and landscape analysis.
Igor Toskin, Maurine Murtagh, Rosanna W Peeling, Karel Blondeel, Joanna Cordero, James Kiarie. Sex Transm Infect 2017
23
10

Beyond diagnostic accuracy: the clinical utility of diagnostic tests.
Patrick M M Bossuyt, Johannes B Reitsma, Kristian Linnet, Karel G M Moons. Clin Chem 2012
188
10


Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6].
Richard J Willke, Peter J Neumann, Louis P Garrison, Scott D Ramsey. Value Health 2018
39
10

American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.
Lowell E Schnipper, Nancy E Davidson, Dana S Wollins, Courtney Tyne, Douglas W Blayney, Diane Blum, Adam P Dicker, Patricia A Ganz, J Russell Hoverman, Robert Langdon,[...]. J Clin Oncol 2015
617
10

An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2].
Louis P Garrison, Mark V Pauly, Richard J Willke, Peter J Neumann. Value Health 2018
91
10

Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3].
Darius N Lakdawalla, Jalpa A Doshi, Louis P Garrison, Charles E Phelps, Anirban Basu, Patricia M Danzon. Value Health 2018
175
10

Evaluating Frameworks That Provide Value Measures for Health Care Interventions.
Jeanne S Mandelblatt, Scott D Ramsey, Tracy A Lieu, Charles E Phelps. Value Health 2017
36
10

Personal utility in genomic testing: a systematic literature review.
Jennefer N Kohler, Erin Turbitt, Barbara B Biesecker. Eur J Hum Genet 2017
67
10


The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought.
Thomas Wilkinson, Mark J Sculpher, Karl Claxton, Paul Revill, Andrew Briggs, John A Cairns, Yot Teerawattananon, Elias Asfaw, Ruth Lopert, Anthony J Culyer,[...]. Value Health 2016
121
10

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.
Don Husereau, Michael Drummond, Stavros Petrou, Chris Carswell, David Moher, Dan Greenberg, Federico Augustovski, Andrew H Briggs, Josephine Mauskopf, Elizabeth Loder. Pharmacoeconomics 2013
97
10

Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis.
Swati Jha, Nazir Ismail, David Clark, James J Lewis, Shaheed Omar, Andries Dreyer, Violet Chihota, Gavin Churchyard, David W Dowdy. PLoS One 2016
7
28

Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach.
Ivor Langley, Hsien-Ho Lin, Saidi Egwaga, Basra Doulla, Chu-Chang Ku, Megan Murray, Ted Cohen, S Bertel Squire. Lancet Glob Health 2014
46
10


Charting a roadmap for heart failure biomarker studies.
Tariq Ahmad, Mona Fiuzat, Michael J Pencina, Nancy L Geller, Faiez Zannad, John G F Cleland, James V Snider, Stephan Blankenberg, Kirkwood F Adams, Rita F Redberg,[...]. JACC Heart Fail 2014
72
5

The efficacy of diagnostic imaging.
D G Fryback, J R Thornbury. Med Decis Making 1991
863
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.